Entactogens, MDMA, and Bringing New Love Drugs To Market | Matthew Baggott ~ ATTMind 177
Release Date: 06/02/2023
Adventures Through The Mind
Renowned consciousness researcher Chris Bache PhD shares profound insights on what it means to be a good person from a psychedelic perspective. He describes mystical experiences of oneness where goodness flows naturally, discusses the challenge of integrating peak experiences into daily life, and explains why spiritual practice and community are essential for embodying the truths we've glimpsed. ... This is a clip from 'Global Collapse, Spirituality, and The Birth Of The Future Human | Chris Bache, Ph.D.', Adventures Through The Mind Podcast, episode 142 FULL INTERVIEW Check Out...
info_outlineAdventures Through The Mind
Psychedelic researchers James Fadiman and Jordan Gruber discuss microdosing protocols, benefits, current research, and safety considerations. Throughout the interview, you will learn the practical basics of psychedelic microdosing—substances, dosage, frequency and duration, when in the larger arc of our lives, and who would best benefit from microdosing; You will also learn about the benefits of microdosing that Gruber and Faidman discovered in their research, which they describe as A-Z, anorexia to zoster and everything in between—with a particular focus later on in the interview on...
info_outlineAdventures Through The Mind
Author and couple's therapist, Charles Wininger discusses how MDMA can serve as "emotional superglue" for relationships by enhancing empathy, creating safety, and improving communication. He explains how the medicine helps couples move from defensive patterns to vulnerability, allowing them to address underlying fears and reconnect. Check our Wininger's book on MDMA for couples, ... This is a clip from 'MDMA for Couples | The Love Doctor, Charley Wininger ~ ATTMind Podcast 138' FULL INTERVIEW SUPPORT THE PODCAST 🥰 Other options Toss me a tip on PayPal: Buy some...
info_outlineAdventures Through The Mind
🥰 👈 We deep dive into psychedelics as treatment for chronic pain with Dr. Alex Bekker, Professor and Chairman of Anaesthesiology at Rutgers New Jersey Medical School. We explore what chronic pain is, how it differs from acute pain, and its connection to maladaptive neuroplasticity. Dr. Bekker unpacks why current treatments often fail and how psychedelics—the classical psychedelics as well as ketamine—may effectively treat otherwise treatment-resistant conditions, as well as some practical advice for chronic pain sufferers. Enjoy! 🌀 FULL TOPICS...
info_outlineAdventures Through The Mind
Matthew Baggott discusses the phenomenon of "losing the magic" with MDMA use, where frequent users experience diminishing therapeutic effects over time, likely due to decreased serotonin transporters in the brain; as well as N-Acetyl Cysteine (NAC) supplementation as a potential avenue for getting the magic back. ... This is a clip from 'Entactogens, MDMA, and Bringing New Love Drugs To Market | Matthew Baggott ~ ATTMind Podcast 177' FULL INTERVIEW SUPPORT THE PODCAST 🥰 Other options Toss me a tip on PayPal: Buy some merchandise: More Options: ▷...
info_outlineAdventures Through The Mind
🥰 👈 Jerónimo Mazarrasa is Program Director at (also known as ICEERS), which is a non-profit organization dedicated to transforming society’s relationship with Traditional Indigenous Medicines. He is also founder of ICEERS Academy, and creator , an online course for people interested in increasing the safety of ayahuasca ceremonies. Our interview with Jerónimo is going to explore the vulnerability of increased suggestibility while the influence of ayahuasca (and other psychedelics), and the various harms that can can incur when one's facilitator that suggestibility...
info_outlineAdventures Through The Mind
Facilitator Chad Charles discusses the dangers of excessive 5-MeO-DMT use in participants and facilitators, as well as how to notice when people need help. ... This is a clip from 'Building Best Practices In The Underground Subculture Of 5-MeO-DMT | Chad Charles', Adventures Through The Mind Podcast, episode 113 FULL INTERVIEW What happened to Tobias SUPPORT THE PODCAST 🥰 Other options Toss me a tip on PayPal: Buy some merchandise: More Options: ▷ Sponsor: Use the promo code JESSO for 15% off your First order Connect with Me Bluesky: Instagram: Newsletter:...
info_outlineAdventures Through The Mind
🥰 👈 Dr. Mikael Palner is an associate professor in the Department of Clinical Research at the University of Southern Denmark, studying the biological correlates of maladaptive neuropsychiatric diseases—such as anxiety, obsessive-compulsive disorder, post-traumatic stress syndrome. He joins us to discuss his research on the positive effects of psilocybin microdosing on stress resiliency, compulsions, and neuroplasticity; as well as what microdosing IS NOT good for, and some important cautions to consider with respect to potential harms of microdosing. We also discuss why...
info_outlineAdventures Through The Mind
Justin Townsend of MycoMeditations retreat center in Jamaica discusses psilocybin-induced psychotic states and how to respond to them. In particular, how to differentiate between what he calls a "normal psychotomimetic response" and a psychotic episode; and how knowing the difference is important in supporting people undergoing these experiences, safely. ... This is a clip from 'The Business and Practice of Psilocybin Therapy in Jamaica | Justin Townsend' ~ ATTMind Podcast 170 Watch in Video here: Full Episode and show notes here: SUPPORT THE PODCAST ...
info_outlineAdventures Through The Mind
EPISODE DETAILS Nicholas P. Money is Professor of Biology and Western Program Director at Miami University in Oxford, Ohio. He is an international expert on fungal biology and author of popular science books that celebrate the microbial world including his most recent, Molds, Mushrooms, and Medicines: Our Lifelong Relationship with Fungi (2024) He joins us on the podcast to deep dive into the biology, ecology, and intelligence of fungi. We discuss the body and life cycle of mushrooming fungi; the shape and behaviour of mycelium; how fungi are more similar to humans than they...
info_outlineThis episode features Matthew Baggott of Tactogen Inc. and will explore entactogens, which are drugs like MDMA, 2C-B, and Methalone.
We start with setting a basic framework for what an entactogen is and a few example drugs, before exploring the complexities in their various effects, mechanisms of action, and both the legislative and technical process of the development of novel or new entactogenic drugs.
...
For links to Baggott's work, full show notes, and a link to watch this episode in video, head to bit.ly/ATTMind177
*** FULL TOPICS BREAKDOWN BELOW**
SUPPORT THE PODCAST
- Patreon: https://patreon.com/jameswjesso
- Paypal Donation: https://www.paypal.com/biz/fund?id=383635S3BKJVS
- Merchandise: https://www.jameswjesso.com/shop/
- More Options: https://www.jameswjesso.com/support
- Newsletter: https://www.jameswjesso.com/newsletter
- Telgram Channel: https://t.me/jameswjesso
*** Extra BIG thanks to my patrons on Patreon for helping keep this podcast alive!
Especially my $23+ patrons, Andreas D, Ian C, Yvette FC, Alex F, Eliz C, Nick M, Joe A, Nanci BF, & Heartwood Mushrooms ——
Episode Breakdown
- (0:00) Opening
- (2:44) Guest Bio
- (4:06) Patreon thanks | Support The Show
- (5:42) Interview begins
- (6:31) What is an entactogen and what does it do? | The difference between entactogens and psychedelics
- (8:37) A short discussion about 2C-B
- (11:47) A list of different entactogens
- (15:30) r-MDMA vs s-MDMA
- (19:48) Methalone, aka bk-MDMA
- (21:52) 3-MMC and 4-MMC: patents, development, and legality
- (23:13) Why Schedule 1 makes drug development difficult
- (25:02) The qualities they are trying to design OUT of new entactogen drugs (pt1)
- (26:31) “The loss of magic” with MDMA
- (33:11) Serotin transporters and MDMA neuro-oxidization
- (36:27) Using NAC to bring back the MDMA magic | enhanced plasticity, antioxidants, and homeostasis
- (44:13) The qualities they are trying to design OUT of new entactogen drugs (pt2)
- (48:52) Why we need “take home” entactogenic drugs
- (53:20) Can a drug still be medicine if it’s fun, too?
- (58:13) The process of justifying off-label MDMA prescriptions
- (1:03:01) Will there be a moral backlash against the development of “good feel” drugs?
- (1:11:10) The negative social consequences of prohibitionist law enforcement
- (1:15:58) We can’t just give people psychedelics and expect society will get better
- (1:18:46) Problematic moves in the psychedelic biotech industry
- (1:25:01) Psychedelic Patent Trolling
- (1:32:15) How Tactogen is trying to give back to psychedelic users
- (1:44:16) Increasing access to health care, not just to psychedelic substances
- (1:49:40) Follow-up link and contact details
- (1:51:25) closing